These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18783074)

  • 41. Cell-free DNA and RNA in plasma as new tools for molecular diagnostics.
    Wong BC; Lo YM
    Expert Rev Mol Diagn; 2003 Nov; 3(6):785-97. PubMed ID: 14628906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations.
    Tong YK; Ding C; Chiu RW; Gerovassili A; Chim SS; Leung TY; Leung TN; Lau TK; Nicolaides KH; Lo YM
    Clin Chem; 2006 Dec; 52(12):2194-202. PubMed ID: 17040955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Size fractionation of cell-free DNA in maternal plasma improves the detection of a paternally inherited beta-thalassemia point mutation by MALDI-TOF mass spectrometry.
    Li Y; Di Naro E; Vitucci A; Grill S; Zhong XY; Holzgreve W; Hahn S
    Fetal Diagn Ther; 2009; 25(2):246-9. PubMed ID: 19506384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of the placental epigenetic signature of the maspin gene in maternal plasma.
    Chim SS; Tong YK; Chiu RW; Lau TK; Leung TN; Chan LY; Oudejans CB; Ding C; Lo YM
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14753-8. PubMed ID: 16203989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis.
    Wright CF; Burton H
    Hum Reprod Update; 2009; 15(1):139-51. PubMed ID: 18945714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating nucleic acids and proteomics of plasma/serum: clinical utility.
    Taback B; Hoon DS
    Ann N Y Acad Sci; 2004 Jun; 1022():1-8. PubMed ID: 15251932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-invasive prenatal diagnosis of single-gene disorders from maternal blood.
    Bustamante-Aragonés A; Rodríguez de Alba M; Perlado S; Trujillo-Tiebas MJ; Arranz JP; Díaz-Recasens J; Troyano-Luque J; Ramos C
    Gene; 2012 Aug; 504(1):144-9. PubMed ID: 22561692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic potential of circulating nucleic acids for oncology.
    Goessl C
    Expert Rev Mol Diagn; 2003 Jul; 3(4):431-42. PubMed ID: 12877383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating nucleic acids in plasma and serum: an overview.
    Lo YM
    Ann N Y Acad Sci; 2001 Sep; 945():1-7. PubMed ID: 11708462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma.
    Lun FM; Chiu RW; Chan KC; Leung TY; Lau TK; Lo YM
    Clin Chem; 2008 Oct; 54(10):1664-72. PubMed ID: 18703764
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fetal nucleic acids in maternal plasma: from biology to clinical translation.
    Bunkar N; Bhargava A; Chaudhury K; Sharma RS; Lohiya NK; Mishra PK
    Front Biosci (Landmark Ed); 2018 Jan; 23(3):397-431. PubMed ID: 28930553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genotyping single nucleotide polymorphisms by MALDI mass spectrometry in clinical applications.
    Tost J; Gut IG
    Clin Biochem; 2005 Apr; 38(4):335-50. PubMed ID: 15766735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Noninvasive prenatal testing beyond genomic analysis: what the future holds.
    Hui WW; Chiu RW
    Curr Opin Obstet Gynecol; 2016 Apr; 28(2):105-10. PubMed ID: 26866842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of tumor mutations in the presence of excess amounts of normal DNA.
    Sun X; Hung K; Wu L; Sidransky D; Guo B
    Nat Biotechnol; 2002 Feb; 20(2):186-9. PubMed ID: 11821866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of fetal DNA detection in maternal plasma: a prenatal diagnosis unit experience.
    González-González C; Garcia-Hoyos M; Trujillo-Tiebas MJ; Lorda-Sanchez I; de Alba MR; Infantes F; Gallego J; Diaz-Recasens J; Ayuso C; Ramos C
    J Histochem Cytochem; 2005 Mar; 53(3):307-14. PubMed ID: 15750008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating fetal DNA: its origin and diagnostic potential-a review.
    Bianchi DW
    Placenta; 2004 Apr; 25 Suppl A():S93-S101. PubMed ID: 15033315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolating fetal cells from maternal blood. Advances in prenatal diagnosis through molecular technology.
    Simpson JL; Elias S
    JAMA; 1993 Nov; 270(19):2357-61. PubMed ID: 8230600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Qualitative and quantitative genotyping using single base primer extension coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MassARRAY).
    Oeth P; del Mistro G; Marnellos G; Shi T; van den Boom D
    Methods Mol Biol; 2009; 578():307-43. PubMed ID: 19768603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular genetic testing for prenatal diagnosis.
    Tantravahi U; Wheeler P
    Clin Lab Med; 2003 Jun; 23(2):481-502. PubMed ID: 12848455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review: advances in non-invasive prenatal diagnosis.
    Vaiopoulos AG; Athanasoula KC; Papantoniou N; Kolialexi A
    In Vivo; 2013; 27(2):165-70. PubMed ID: 23422474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.